Astrocyte mitochondria: A substrate for iron deposition in the aging rat substantia nigra

Experimental Neurology

Volumn 152, Issue 2, 1998, Pages 188-196

  Schipper, Hyman M ^a   Vininsky, Rachelle ^a   Brull, Richard ^a   Small, Lorne ^a   Brawer, James R ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Aging; Astrocyte; Iron; Oxidative stress; Parkinson's disease; Substantia nigra

Indexed keywords

IRON;

ADOLESCENT; AGED; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN MITOCHONDRION; MALE; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

EID: 0032143836     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6854     Document Type: Article

References (33)

1. Beal M. F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses. Ann. Neurol. 31:1992;119-130.
2. Beal, M. F. 1995, Mitochondrial Dysfunction and Oxidative Damage in Neurodegenerative Diseases, 1, 128, R. G. Landes, Austin, TX.
3. Brawer J. R., Reichard G., Small L., Schipper H. M. The origin and composition of peroxidase-positive granules in cysteamine-treated astrocytes in culture. Brain Res. 633:1994;9-20.
4. Brawer J. R., Stein R., Small L., Cissé S., Schipper H. M. Composition of Gomori-positive inclusions in astrocytes of the hypothalamic arcuate nucleus. Anat. Rec. 240:1994;407-415.
5. Chopra V. S., Chalifour L. E., Schipper H. M. Differential effects of cysteamine on heat shock protein induction and cytoplasmic granulation in astrocytes and glioma cells. Mol. Brain Res. 31:1995;173-184.
6. Cohen G., Werner P. Free radicals, oxidative stress, and neurodegeneration. Neurodegenerative Diseases. 1994;Saunders, Philadelphia. p. 1319-1361.
7. Connor J. R., Menzles S., St. Martin S. M., Mufson E. J. Cellular distribution of transferrin, ferritin and iron in normal and aged human brains. J. Neurosci. 27:1990;595-611.
8. DiMonte D. A., Schipper H. M., Hetts S., Langston J. W. Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures. Glia. 15:1995;203-206.
9. Frankel D., Schipper H. M. Does astroglial senescence facilitate oxidative neuronal injury. Soc. Neurosci. Abst. 23:1997;1371.
10. Goldfischer S., Villaverde H., Forschirm R. The demonstration of acid hydrolase, thermostable-reduced diphosphopyridine nucleotide tetrazolium reductase and peroxidase activities in human lipofuscin pigment granules. J. Histochem. Cytochem. 14:1966;641.
11. Jellinger P., Paulus W., Grundke-Iqbal I., Riederer P., Youdim M. B. Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J. Neural Trans. Park. Dis. Dement. Sect. 2:1990;327-340.
12. Jenner P. What process causes nigral cell death in Parkinson's disease. Cederbaum J. M., Gancher S. T. Neurological Clinics. 2. Parkinson's Disease. 1992;387-403 Saunders, Philadelphia.
13. Justino L., Welner S. A., Tannenbaum G. S., Schipper H. M. Long-term effects of cysteamine on cognitive and locomotor behavior in rats: Relationship to hippocampal glial pathology and somatostatin levels. Brain Res. 761:1997;127-134.
14. Keefer D. A., Christ J. F. Distribution of endogenous diaminobenzidine-staining cells in the normal rat brain. Brain Res. 116:1976;312.
15. Manganaro F., Chopra V. S., Mydlarski M. B., Bernatchez G., Schipper H. M. Redox perturbations in cysteamine-stressed astroglia: Implications for inclusion formation and gliosis in the aging brain. Free Rad. Biol. Med. 19:1995;823-835.
16. McLaren J., Brawer J. R., Schipper H. M. Iron content correlates with peroxidase activity in cysteamine-induced astroglial organelles. J. Histochem. Cytochem. 40:1992;1887-1897.
17. Metodiewa D., Reszka K., Dunford H. Evidence for a peroxidatic oxidation of norepinephrine, a catecholamine, by lactoperoxidase. Biochem. Biophys. Res. Commun. 160:1989;1183.
18. Morris C. M., Edwardson J. A. Iron histochemistry of the substantia nigra in Parkinson's disease. Neurodegeneration. 3:1994;277-282.
19. Mydlarski M. B., Liang J. J., Schipper H. M. Role of the cellular stress response in the biogenesis of cysteamine-induced astrocytic inclusions in primary culture. J. Neurochem. 61:1993;1755-1765.
20. Mydlarski M. B., Schipper H. M. Stress protein co-localization to autofluorescent astrocytic inclusionin situ. Brain Res. 627:1993;113-121.
21. Olanow C. W. Magnetic resonance imaging in parkinsonism. Cederbaum J. M., Gancher S. T. Neurological Clinics. 1992;405-420 Saunders, Philadelphia.
22. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, New York.
23. Reichmann H., Riederer P. Mitochondrial disturbances in neurodegeneration. Calne D. B. Neurodegenerative Diseases. 1994;195-204 Saunders, Philadelphia.
24. Riederer P., Sofic E., Rausch W. D., Schmidt B., Reynolds G. P., Jellinger K., Youdim M. B. H. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52:1989;515-520.
25. Schipper H. M. Gomori-positive astrocytes: biological properties and implications for neurologic and neuroendocrine disorders. Glia. 4:1991;365-377.
26. Schipper H. M. Astrocytes, brain aging and neurodegeneration. Neurobiol. Aging. 17:1996;467-480.
27. Schipper H. M., Cissé S. Mitochondrial constituents of corpora amylacea and autofluorescent astrocytic inclusions in senescent human brain. Glia. 14:1995;55-64.
28. Schipper H. M., Kotake Y., Janzen E. G. Catechol oxidation by peroxidase-positive astrocytes in primary culture: an electron spin resonance study. J. Neurosci. 11:1991;2170-2176.
29. Schipper H. M., Mateescu-Cantuniari A. Identification of peroxidase-positive astrocytes by combined histochemical and immunolabeling techniques in situ and in cell culture. J. Histochem. Cytochem. 39:1991;1009-1016.
30. Schipper H. M., Mydlarski M. B., Wang X. Cysteamine gliopathy in situ: A cellular stress model for the biogen-esis of astrocytic inclusions. J. Neuropathol. Exp. Neurol. 52:1993;399-410.
31. Schipper H. M., Scarborough D. E., Lechan R. M., Reichlin S. Gomori-positive astrocytes in primary culture: effects ofin vitro. Dev. Brain Res. 54:1990;71-79.
32. Soong N. W., Hinton D. R., Cortopassi G., Arnheim N. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nature Genet. 2:1992;318-323.
33. Youdim M. B. H. Inorganic neurotoxins in neurodegenerative disorders without primary dementia. Calne D. B. Neurodegenerative Diseases. 1994;251-276 Saunders, Philadelphia.